|Name, symbol, number||xenon, Xe, 54|
|Group, period, block||18, 5, p|
|Standard atomic weight||131.293(6) g·mol−1|
|Electron configuration||[Kr] 4d10 5s2 5p6|
|Electrons per shell||2, 8, 18, 18, 8|
| Physical properties<tr><td>Phase</td><td>gas</td></tr><tr><td>Density</td><td>(0 °C, 101.325 kPa)|
5.894 g/L</td></tr><tr><td>Melting point</td><td>(101.325 kPa) 161.4 K
(−111.7 °C, −169.1 °F)</td></tr><tr><td>Boiling point</td><td>(101.325 kPa) 165.03 K
(−108.12 °C, −162.62 °F)</td></tr><tr><td>Triple point</td><td>161.405 K (-112°C), 81.6 kPa</td></tr><tr><td>Critical point</td><td>289.77 K, 5.841 MPa</td></tr><tr><td>Heat of fusion</td><td>(101.325 kPa) 2.27 kJ·mol−1</td></tr><tr><td>Heat of vaporization</td><td>(101.325 kPa) 12.64 kJ·mol−1</td></tr><tr><td>Heat capacity</td><td>(100 kPa, 25 °C) 20.786 J·mol−1·K−1</td></tr>
| Atomic properties
<tr><td>Crystal structure</td><td>cubic face centered</td></tr><tr><td>Oxidation states</td><td>0, +1, +2, +4, +6, +8
|Ionization energies||1st: 1170.4 kJ/mol|
|2nd: 2046.4 kJ/mol|
|3rd: 3099.4 kJ/mol|
WikiDoc Resources for
Evidence Based Medicine
Guidelines / Policies / Govt
Patient Resources / Community
Healthcare Provider Resources
Continuing Medical Education (CME)
Experimental / Informatics
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us  to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Xenon (pronounced /ˈzɛnɒn/ in the UK, /ˈziːnɒn/ in the US) is a chemical element that has the symbol Xe and atomic number 54. A colorless, heavy, odorless noble gas, xenon occurs in the earth's atmosphere in trace amounts. Although generally unreactive, xenon can undergo a few chemical reactions such as the formation of xenon hexafluoroplatinate, the first noble gas compound to be synthesized.
Naturally occurring xenon is made of nine stable isotopes, but there are also over 40 unstable isotopes that undergo radioactive decay. The isotope ratios of xenon are an important tool for studying the early history of the Solar System. Xenon-135 is produced as a result of nuclear fission and acts as a neutron absorber in nuclear reactors.
Xenon is used in flash lamps and arc lamps, and as a general anesthetic. The first excimer laser design used a xenon dimer molecule (Xe2) as its lasing medium, and the earliest laser designs used xenon flash lamps as pumps. Xenon is also being used to search for hypothetical weakly interactive massive particles and as the propellant for ion thrusters in spacecraft.
Xenon was discovered in England by William Ramsay and Morris Travers on July 12, 1898, shortly after their discovery of the elements krypton and neon. They found it in the residue left over from evaporating components of liquid air. Ramsay suggested the name xenon for this gas from the Greek word ξένον [xenon], neuter singular form of ξένος [xenos], meaning foreign, strange, or host. In 1902, Ramsay estimated the proportion of xenon in the Earth's atmosphere as one part in 20 million.
During the 1930s, the engineer Harold Edgerton began exploring strobe light technology for high-speed photography. This led him to the invention of the xenon flash lamp, in which light is generated by sending a brief electrical current through a tube filled with xenon gas. In 1934, Edgerton was able to generate flashes as brief as one microsecond with this method.
Albert R. Behnke Jr. began exploring the causes of "drunkenness" in deep-sea divers in 1939. He tested the effects of varying the breathing mixtures on his subjects, and discovered that this caused the divers to perceive a change in depth. From his results, he deduced that xenon gas could serve as an anesthetic. Although Lazharev, in Russia, apparently studied xenon anesthesia in 1941, the first published report confirming xenon anesthesia was in 1946 by J. H. Lawrence, who experimented on mice. Xenon was first used as a surgical anesthetic in 1951 by Stuart C. Cullen, who successfully operated on two patients.
In 1960, the physicist John H. Reynolds discovered that certain meteorites contained an isotopic anomaly in the form of an overabundance of xenon-129. He inferred that this was a decay product of radioactive iodine-129. As the half-life of 129I is 16 million years, this demonstrated that the meteorites were formed during the early history of the Solar System, as the 129I isotope was likely generated before the Solar System was formed.
Xenon and the other noble gases were for a long time considered to be completely chemically inert and not able to form compounds. However, while teaching at the University of British Columbia, Neil Bartlett discovered that the gas platinum hexafluoride (PtF6) was a powerful oxidizing agent that could oxidize oxygen (O2) to form dioxygenyl hexafluoroplatinate (O2+[PtF6]−). Since O2 and xenon have almost the same first ionization potential, Bartlett realized that platinum hexafluoride might also be able to oxidize xenon. On March 23, 1962, he mixed the two gases and produced the first known compound of a noble gas, xenon hexafluoroplatinate. Bartlett thought its composition to be Xe+[PtF6]−, although later work has revealed that it was probably a mixture of various xenon-containing salts. Since then, many other xenon compounds have been discovered, and some compounds of the noble gases argon, krypton, and radon have been identified, including argon fluorohydride (HArF), krypton difluoride (KrF2), and radon fluoride.
Xenon is a trace gas in Earth's atmosphere, occurring at 0.087±0.001 parts per million (μL/L). It is also found in gases emitted from some mineral springs. Some radioactive species of xenon, for example, 133Xe and 135Xe, are produced by neutron irradiation of fissionable material within nuclear reactors.
Xenon is obtained commercially as a byproduct of the separation of air into oxygen and nitrogen. After this separation, generally performed by fractional distillation in a double-column plant, the liquid oxygen produced will contain small quantities of krypton and xenon. By additional fractional distillation steps, the liquid oxygen may be enriched to contain 0.1–0.2% of a krypton/xenon mixture, which is extracted either via adsorption onto silica gel or by distillation. Finally, the krypton/xenon mixture may be separated into krypton and xenon via distillation. Extraction of a liter of xenon from the atmosphere requires 220 watt-hours of energy. Worldwide production of xenon in 1998 was estimated at 5,000–7,000 m3. Due to its low abundance, xenon is much more expensive than the lighter noble gases—approximate prices for the purchase of small quantities in Europe in 1999 were 10 €/L for xenon, 1 €/L for krypton, and 0.20 €/L for neon.
Xenon is relatively rare in the Sun's atmosphere, on Earth, and in the asteroids and comets. The atmosphere of Mars shows a similar xenon abundance to that of Earth: 0.08 parts per million. However, Mars shows a higher proportion of 129Xe than the Earth or the Sun. As this isotope is generated by radioactive decay, the result may indicate that Mars lost most of its primordial atmosphere, possibly within the first 100 million years after the planet was formed. By contrast, the planet Jupiter has an unusually high abundance of xenon in its atmosphere; about 2.6 times as much as the Sun. This high abundance remains unexplained, but may have been caused by an early and rapid buildup of planetesimals—small, subplanetary bodies—before the presolar disk began to heat up. (Otherwise, xenon would not have been trapped in the planetesimal ices.) Within the Solar System, the nucleon fraction for all isotopes of xenon is 1.56 × 10-8, or one part in 64 million of the total mass. The problem of the low terrestrial xenon may potentially be explained by covalent bonding of xenon to oxygen within quartz, hence reducing the outgassing of xenon into the atmosphere.
Unlike the lower mass noble gases, the normal stellar nucleosynthesis process inside a star does not form xenon. Elements more massive than iron-56 have a net energy cost to produce through fusion, so there is no energy gain for a star to create xenon. Instead, many isotopes of xenon are formed during supernova explosions.
An atom of xenon is defined as having a nucleus with 54 protons. At standard temperature and pressure, pure xenon gas has a density of 5.761 kg/m3, about 4.5 times the surface density of the Earth's atmosphere, 1.217 kg/m3. As a liquid, xenon has a density of up to 3.100 g/mL, with the density maximum occurring at the triple point. Under the same conditions, the density of solid xenon, 3.640 g/cm3, is larger than the average density of granite, 2.75 g/cm3. Using gigapascals of pressure, xenon has been forced into a metallic phase.
Xenon is a member of the zero-valence elements that are called noble or inert gases. It is inert to most common chemical reactions (such as combustion, for example) because the outer valence shell is completely filled with eight electrons. This produces a stable, minimum energy configuration in which the outer electrons are tightly bound. However, xenon can be oxidized by powerful oxidizing agents, and many xenon compounds have been synthesized.
In a gas-filled tube, xenon emits a blue or lavenderish glow when the gas is excited by electrical discharge. Xenon emits a band of emission lines that span the visual spectrum, but the most intense lines occur in the region of blue light, which produces the coloration.
Naturally occurring xenon is made of nine stable isotopes. The isotopes 124Xe, 134Xe and 136Xe are predicted to undergo double beta decay, but this has never been observed so they are considered to be stable. Besides these stable forms, there are over 40 unstable isotopes that have been studied. 129Xe is produced by beta decay of 129I, which has a half-life of 16 million years, while 131mXe, 133Xe, 133mXe, and 135Xe are some of the fission products of both 235U and 239Pu, and therefore used as indicators of nuclear explosions. The various isotopes of xenon are produced from supernova explosions, red giant stars that have exhausted the hydrogen at their cores and entered the asymptotic giant branch, classical novae explosions and the radioactive decay of elements such as iodine, uranium and plutonium.
The artificial isotope 135Xe is of considerable significance in the operation of nuclear fission reactors. 135Xe has a huge cross section for thermal neutrons, 2.6×106 barns, so it acts as a neutron absorber or "poison" that can slow or stop the chain reaction after a period of operation. This was discovered in the earliest nuclear reactors built by the American Manhattan Project for plutonium production. Fortunately the designers had made provisions in the design to increase the reactor's reactivity (the number of neutrons per fission that go on to fission other atoms of nuclear fuel).
Under adverse conditions, relatively high concentrations of radioactive xenon isotopes may be found emanating from nuclear reactors due to the release of fission products from cracked fuel rods, or fissioning of uranium in cooling water.
Because xenon is a tracer for two parent isotopes, xenon isotope ratios in meteorites are a powerful tool for studying the formation of the solar system. The iodine-xenon method of dating gives the time elapsed between nucleosynthesis and the condensation of a solid object from the solar nebula. Xenon isotopic ratios such as 129Xe/130Xe and 136Xe/130Xe are also a powerful tool for understanding terrestrial differentiation and early outgassing. Excess 129Xe found in carbon dioxide well gases from New Mexico was believed to be from the decay of mantle-derived gases soon after Earth's formation.
Xenon hexafluoroplatinate was the first chemical compound of xenon, synthesized in 1962. Following this, many additional compounds of xenon have been discovered. These include xenon difluoride (XeF2), xenon tetrafluoride (XeF4), xenon hexafluoride (XeF6), xenon tetroxide (XeO4), and sodium perxenate (Na4XeO6). A highly explosive compound, xenon trioxide (XeO3), has also been made. Most of the more than 80 xenon compounds found to date contain electro-negative fluorine or oxygen. When other atoms are bound (such as hydrogen or carbon), they are often part of a molecule containing fluorine or oxygen. Some compounds of xenon are colored but most are colorless.
In 1995, a group of scientists at the University of Helsinki in Finland (M. Räsänen and co-workers) announced the preparation of xenon dihydride (HXeH), and later xenon hydride-hydroxide (HXeOH), hydroxenoacetylene (HXeCCH), and other Xe-containing molecules.  Deuterated molecules, HXeOD and DXeOH, have also been produced.
As well as compounds where xenon forms a chemical bond, xenon can form clathrates—substances where xenon atoms are trapped by the crystalline lattice of another compound. An example is xenon hydrate (Xe·5.75 H2O), where xenon atoms occupy vacancies in a lattice of water molecules. The deuterated version of this hydrate has also been produced. Such clathrate hydrates can occur naturally under conditions of high pressure, such as in Lake Vostok underneath the Antarctic ice sheet. Clathrate formation can be used to fractionally distill xenon, argon and krypton. Xenon can also form endohedral fullerene compounds, where a xenon atom is trapped inside a fullerene molecule. The xenon atom trapped in the fullerene can be monitored via 129Xe nuclear magnetic resonance spectroscopy. Using this technique, chemical reactions on the fullerene molecule can be analyzed, due to the sensitivity of the chemical shift of the xenon atom to its environment. However, the xenon atom also has an electronic influence on the reactivity of the fullerene.
Although xenon is rare and relatively expensive to extract from the Earth's atmosphere, it still has a number of applications.
Illumination and optics
Xenon is used in light-emitting devices called xenon flash lamps, which are used in photographic flashes and stroboscopic lamps; to excite the active medium in lasers which then generate coherent light; and, occasionally, in bactericidal lamps. The first solid-state laser, invented in 1960, was pumped by a xenon flash lamp, and lasers used to power inertial confinement fusion are also pumped by xenon flash lamps.
Continuous, short-arc, high pressure xenon arc lamps have a color temperature closely approximating noon sunlight and are used in solar simulators. That is, the chromaticity of these lamps closely approximates a heated black-body radiator that has a temperature close to that observed from the Sun. After they were first introduced during the 1940s, these lamps began replacing the shorter-lived carbon arc lamps in movie projectors. They are employed in typical 35mm and IMAX film projection systems, automotive HID headlights and other specialized uses. These arc lamps are an excellent source of short wavelength ultraviolet radiation and they have intense emissions in the near infrared, which is used in some night vision systems.
The individual cells in a plasma display use a mixture of xenon and neon that is converted into a plasma using electrodes. The interaction of this plasma with the electrodes generates ultraviolet photons, which then excite the phosphor coating on the front of the display.
Xenon is used as a "starter gas" in high pressure sodium lamps. It has the lowest thermal conductivity and lowest ionization potential of all the non-radioactive noble gases. As a noble gas, it does not interfere with the chemical reactions occurring in the operating lamp. The low thermal conductivity minimizes thermal losses in the lamp while in the operating state, and the low ionization potential causes the breakdown voltage of the gas to be relatively low in the cold state, which allows the lamp to be more easily started.
In 1962, a group of researchers at Bell Laboratories discovered laser action in xenon, and later found that the laser gain was improved by adding helium to the lasing medium. The first excimer laser used a xenon dimer (Xe2) energized by a beam of electrons to produce stimulated emission at an ultraviolet wavelength of 176 nm. Xenon chloride and xenon fluoride have also been used in excimer (or, more accurately, exciplex) lasers. The xenon chloride excimer laser has been employed, for example, in certain dermatological uses.
Xenon has been used as a general anesthetic, although it is expensive. Even so, anesthesia machines that can deliver xenon are about to appear on the European market. Two mechanisms for xenon anesthesia have been proposed. The first one involves the inhibition of the calcium ATPase pump—the mechanism cells use to remove calcium (Ca2+)—in the cell membrane of synapses. This results from a conformational change when xenon binds to nonpolar sites inside the protein. The second mechanism focuses on the non-specific interactions between the anesthetic and the lipid membrane.
Xenon has a minimum alveolar concentration (MAC) of 0.63, making it 50% more potent than N2O as an anesthetic. Thus it can be used in concentrations with oxygen that have a lower risk of hypoxia. Unlike nitrous oxide (N2O), xenon is not a greenhouse gas and so it is also viewed as environmentally friendly. Because of the high cost of xenon, however, economic application will require a closed system so that the gas can be recycled, with the gas being appropriately filtered for contaminants between uses.
Gamma emission from the radioisotope 133Xe of xenon can be used to image the heart, lungs, and brain, for example, by means of single photon emission computed tomography. 133Xe has also been used to measure blood flow.
Nuclei of only two of the stable isotopes of xenon, 129Xe and 131Xe, have non-zero intrinsic angular momenta (nuclear spins). When mixed with alkali vapor and nitrogen, their nuclear spins can be aligned along the laser beam of circularly-polarized light that is tuned to an absorption line of the alkali atoms. Typically, pure rubidium metal, heated above 100 °C, is used to produce the alkali vapor. This alignment (spin polarization) of xenon nuclei can surpass 50% of its maximum possible value, greatly exceeding the equilibrium value dictated by the Boltzmann distribution (typically 0.001% of the maximum value at room temperature, even in the strongest magnets). Such non-equilibrium alignment of spins is a temporary condition, and is called hyperpolarization. Because the 129Xe isotope has a nuclear spin value of 1/2 (and therefore the electric quadrupole moment of 129Xe nucleus must be zero), 129Xe nucleus does not experience any quadrupolar interactions during collisions with other atoms, and thus its hyperpolarization can be maintained for long periods of time even after the laser beam has been turned off and the alcali vapor removed by condensation on a room-temperature surface. The time it takes for a collection of spins to return to their equilibrium (Boltzmann) polarization is called the T1 relaxation time. For 129Xe isotope it can range from several seconds for xenon atoms dissolved in blood to several hours in the gas phase and to several days in the deeply-frozen solid xenon. In contrast, the 131Xe isotope has a nuclear spin value of 3/2, does possess a non-zero quadrupole moment, and has T1 relaxation times in the millisecond and second ranges. The hyperpolarization process (such as Spin-Exchange optical pumping described above) renders the 129Xe isotope much more detectable via magnetic resonance imaging and has been used for studies of the lungs and other tissues. It can be used, for example, to trace the flow of gases within the lungs.
In nuclear energy applications, xenon is used in bubble chambers, probes, and in other areas where a high molecular weight and inert nature is desirable. Liquid xenon is being used as a medium for detecting hypothetical weakly interactive massive particles, or WIMPs. When a WIMP collides with a xenon nucleus, it should, theoretically, strip an electron and create a primary scintillation. By using xenon, this burst of energy could then be readily distinguished from similar events caused by particles such as cosmic rays. However, the XENON experiment at the Gran Sasso National Laboratory in Italy has thus far failed to find any confirmed WIMPs. Even if no WIMPs are detected though, the experiment will serve to constrain the properties of dark matter and some physics models. The current detector at this facility is five times as sensitive as other instruments world-wide, and the sensitivity will be increased by an order of magnitude in 2008.
Xenon is the preferred fuel for ion propulsion of spacecraft because of its low ionization potential per atomic weight, the ability to store it as a liquid at near room temperature (but at high pressure) yet easily converts back into a gas to fuel the engine. The inert nature of xenon makes it environmentally friendly and less corrosive to an ion engine than other fuels such as mercury or caesium. Xenon was first used for satellite ion engines during the 1970s. It was later employed as a propellant for Europe's SMART-1 spacecraft and for the three ion propulsion engines on NASA's Dawn Spacecraft.
Chemically, the perxenate compounds are used as oxidizing agents in analytical chemistry. Xenon difluoride is used as an etchant for silicon, particularly in the production of microelectromechanical systems (MEMS). The anticancer drug 5-fluorouracil can be produced by reacting Xenon difluoride with Uracil. Xenon is also used in protein crystallography. Applied at pressures from 0.5 to 5 MPa (5 to 50 atm) to a protein crystal, xenon atoms bind in predominantly hydrophobic cavities, often creating a high quality, isomorphous, heavy-atom derivative, which can be used for solving the phase problem.
Xenon gas can be safely kept in normal sealed glass or metal containers at standard temperature and pressure. However, it readily dissolves in most plastics and rubber, and will gradually escape from a container sealed with such materials. Xenon is non-toxic, although it does dissolve in blood and belongs to a select group of substances that penetrate the blood-brain barrier, causing mild anaesthesia when inhaled in very high concentrations (see anesthesia subsection above). Many of xenon compounds are explosive and toxic due to their strong oxidative properties.
At 169 m/s, the speed of sound in xenon gas is slower than that in air (due to the slower average speed of the heavy xenon atoms compared to nitrogen and oxygen molecules), so xenon lowers the resonant frequencies of the vocal tract when inhaled. This produces a characteristic lowered voice pitch, opposite the high-pitched voice caused by inhalation of helium. Like helium, xenon does not satisfy the body's need for oxygen and is a simple asphyxiant; consequently, many universities no longer allow the voice stunt as a general chemistry demonstration. As xenon is expensive, the gas sulfur hexafluoride, which is similar to xenon in molecular weight (146 versus 131), is generally used in this stunt, although it too is an asphyxiant.
It is possible to safely breathe heavy gases such as xenon or sulfur hexafluoride when they include a 20% mixture of oxygen. The lungs mix the gases very effectively and rapidly, so that the heavy gases are purged along with the oxygen and do not accumulate at the bottom of the lungs. There is, however, a danger associated with any heavy gas in large quantities: it may sit invisibly in a container, and if a person enters a container filled with an odorless, colorless gas, they may find themselves breathing it unknowingly. Xenon is rarely used in large enough quantities for this to be a concern, though the potential for danger exists any time a tank or container of xenon is kept in an unventilated space.
- ↑ Lide, David R. (2004). "Section 4, Properties of the Elements and Inorganic Compounds; Melting, boiling, triple, and critical temperatures of the elements", CRC Handbook of Chemistry and Physics, 85th edition, Boca Raton, Florida: CRC Press. ISBN 0849304857.
- ↑ "xenon", Columbia Electronic Encyclopedia, 6th ed., Columbia University Press, 2007. Accessed on line October 23, 2007.
- ↑ 3.0 3.1 Husted, Robert; Boorman, Mollie (December 15, 2003). Xenon. Los Alamos National Laboratory, Chemical Division. Retrieved on 2007-09-26.
- ↑ Rabinovich, Viktor Abramovich; Vasserman, A. A.; Nedostup, V. I.; Veksler, L. S. (1988). Thermophysical properties of neon, argon, krypton, and xenon, English-language edition, Washington, DC: Hemisphere Publishing Corp.. ISBN 0195218337. —National Standard Reference Data Service of the USSR. Volume 10.
- ↑ 5.0 5.1 Freemantel, Michael (August 25, 2003). Chemistry at its Most Beautiful. Chemical & Engineering News. Retrieved on 2007-09-13.
- ↑ 6.0 6.1 Kaneoka, Ichiro (1998). "Xenon's Inside Story". Science 280 (5365): 851-852. Retrieved on 2007-10-10.
- ↑ 7.0 7.1 Stacey, Weston M. (2007). Nuclear Reactor Physics. Wiley-VCH, p. 213. ISBN 3527406794.
- ↑ 8.0 8.1 8.2 Burke, James (2003). Twin Tracks: The Unexpected Origins of the Modern World. Oxford University Press, 33. ISBN 0743226194.
- ↑ 9.0 9.1 Mellor, David (2000). Sound Person's Guide to Video. Focal Press, p. 186. ISBN 0240515951.
- ↑ Sanders, Robert D.; Ma, Daqing; Maze, Mervyn (2005). "Xenon: elemental anaesthesia in clinical practice". British Medical Bulletin 71 (1): 115-135. Retrieved on 2007-10-02.
- ↑ 11.0 11.1 Basov, N. G.; Danilychev, V. A.; Popov, Yu. M. (1971). "Stimulated Emission in the Vacuum Ultraviolet Region". Soviet Journal of Quantum Electronics 1 (1): 18-22. doi:10.1070/QE1971v001n01ABEH003011.
- ↑ 12.0 12.1 Toyserkani, E.; Khajepour, A.; Corbin, S. (2004). Laser Cladding. CRC Press, 48. ISBN 0849321727.
- ↑ 13.0 13.1 Ball, Philip (May 1, 2002). Xenon outs WIMPs. Nature. Retrieved on 2007-10-08.
- ↑ 14.0 14.1 Saccoccia, G.; del Amo, J. G.; Estublier, D.. "Ion engine gets SMART-1 to the Moon", ESA, August 31, 2006. Retrieved on 2007-10-01.
- ↑ W. Ramsay and M. W. Travers (1898). "On the extraction from air of the companions of argon, and neon". Report of the Meeting of the British Association for the Advancement of Science: 828.
- ↑ Gagnon, Steve. It's Elemental - Xenon. Thomas Jefferson National Accelerator Facility. Retrieved on 2007-06-16.
- ↑ Anonymous (1904). in Daniel Coit Gilman, Harry Thurston Peck, Frank Moore Colby: The New International Encyclopædia. Dodd, Mead and Company, p. 906.
- ↑ Staff (1991). The Merriam-Webster New Book of Word Histories. Merriam-Webster, Inc., p. 513. ISBN 0877796033.
- ↑ Ramsay, William (1902). "An Attempt to Estimate the Relative Amounts of Krypton and of Xenon in Atmospheric Air". Proceedings of the Royal Society of London 71: 421-426. Retrieved on 2007-10-02.
- ↑ Anonymous. History. Millisecond Cinematography. Retrieved on 2007-11-07.
- ↑ Paschotta, Rüdiger (November 1, 2007). Lamp-pumped lasers. Encyclopedia of Laser Physics and Technology. RP Photonics. Retrieved on 2007-11-07.
- ↑ Marx, Thomas; Schmidt, Michael; Schirmer, Uwe; Reinelt, Helmut (2000). "Xenon anesthesia". Journal of the Royal Society of Medicine 93: 513-517. Retrieved on 2007-10-02.
- ↑ Clayton, Donald D. (1983). Principles of Stellar Evolution and Nucleosynthesis, 2nd edition, University of Chicago Press, p. 75. ISBN 0226109534.
- ↑ Bolt, B. A.; Packard, R. E.; Price, P. B. (2007). John H. Reynolds, Physics: Berkeley. The University of California, Berkeley. Retrieved on 2007-10-01.
- ↑ Neil Bartlett and D. H. Lohmann (March 1962). "Dioxygenyl hexafluoroplatinate (V), O2+[PtF6]−". Proceedings of the Chemical Society (3): 115. London: Chemical Society. doi:10.1039/PS9620000097.
- ↑ 26.0 26.1 Bartlett, N. (June 1962). "Xenon hexafluoroplatinate (V) Xe+[PtF6]−". Proceedings of the Chemical Society (6): 218. London: Chemical Society. doi:10.1039/PS9620000197.
- ↑ Graham, L.; Graudejus, O., Jha N.K., and Bartlett, N. (2000). "Concerning the nature of XePtF6". Coordination Chemistry Reviews 197: 321–334. doi:10.1016/S0010-8545(99)00190-3.
- ↑ p. 392, §11.4, Inorganic Chemistry, translated by Mary Eagleson and William Brewer, edited by Bernhard J. Aylett, San Diego: Academic Press, 2001, ISBN 0-12-352651-5; translation of Lehrbuch der Anorganischen Chemie, originally founded by A. F. Holleman, continued by Egon Wiberg, edited by Nils Wiberg, Berlin: de Gruyter, 1995, 34th edition, ISBN 3-11-012641-9.
- ↑ Steel, Joanna (2007). Biography of Neil Bartlett. College of Chemistry, University of California, Berkeley. Retrieved on 2007-10-25.
- ↑ Bartlett, Neil (September 8, 2003). "The Noble Gases". Chemical & Engineering News 81 (36). American Chemical Society. Retrieved on 2007-10-01.
- ↑ Leonid Khriachtchev, Mika Pettersson, Nino Runeberg, Jan Lundell, and Markku Räsänen (August 24, 2000). "A stable argon compound". Nature 406: 874–876. doi:10.1038/35022551.
- ↑ Lynch, C. T.; Summitt, R.; Sliker, A. (1980). CRC Handbook of Materials Science. CRC Press. ISBN 087819231X.
- ↑ D. R. MacKenzie (September 20, 1963). "Krypton Difluoride: Preparation and Handling". Science 141 (3586): 1171. doi:10.1126/science.141.3586.1171.
- ↑ Paul R. Fields, Lawrence Stein, and Moshe H. Zirin (1962). "Radon Fluoride". Journal of the American Chemical Society 84 (21): 4164–4165. doi:10.1021/ja00880a048.
- ↑ Hwang, Shuen-Cheng; Robert D. Lein, Daniel A. Morgan (2005). "Noble Gases", Kirk-Othmer Encyclopedia of Chemical Technology, 5th edition, Wiley. DOI:10.1002/0471238961.0701190508230114.a01. ISBN 047148511X.
- ↑ Kerry, Frank G. (2007). Industrial Gas Handbook: Gas Separation and Purification. CRC Press, pp. 101–103. ISBN 0849390052.
- ↑ Xenon - Xe. CFC StarTec LLC (August 10, 1998). Retrieved on 2007-09-07.
- ↑ 38.0 38.1 Singh, Sanjay (May 15, 2005). Xenon: A modern anaesthetic. Indian Express Newspapers Limited. Retrieved on 2007-10-10.
- ↑ 39.0 39.1 Häussinger, Peter; Reinhard Glatthaar, Wilhelm Rhode, Helmut Kick, Christian Benkmann, Josef Weber, Hans-Jörg Wunschel, Viktor Stenke, Edith Leicht, Hermann Stenger (2001). "Noble Gases", Ullmann's Encyclopedia of Industrial Chemistry, 6th edition, Wiley. DOI:10.1002/14356007.a17_485. ISBN 3527201653.
- ↑ Williams, David R. (September 1, 2004). Mars Fact Sheet. NASA. Retrieved on 2007-10-10.
- ↑ Schilling, James. Why is the Martian atmosphere so thin and mainly carbon dioxide?. Mars Global Circulation Model Group. Retrieved on 2007-10-10.
- ↑ Zahnle, Kevin J. (1993). "Xenological constraints on the impact erosion of the early Martian atmosphere". Journal of Geophysical Research 98 (E6): 10,899–10,913. Retrieved on 2007-10-10.
- ↑ Mahaffy, P. R.; Niemann, H. B.; Alpert, A.; Atreya, S. K.; Demick, J.; Donahue, T. M.; Harpold, D. N.; Owen, T. C. (2000). "Noble gas abundance and isotope ratios in the atmosphere of Jupiter from the Galileo Probe Mass Spectrometer". Journal of Geophysical Research 105 (E6): 15061-15072. Retrieved on 2007-10-01.
- ↑ Owen, Tobias; Mahaffy, Paul; Niemann, H. B.; Atreya, Sushil; Donahue, Thomas; Bar-Nun, Akiva; de Pater, Imke (1999). "A low-temperature origin for the planetesimals that formed Jupiter". Nature 402 (6759): 269-270. Retrieved on 2007-02-04.
- ↑ Arnett, David (1996). Supernovae and Nucleosynthesis. Princeton, New Jersey: Princeton University Press. ISBN 0-691-01147-8.
- ↑ Chrystèle Sanloup et al (2005). "Retention of Xenon in Quartz and Earth's Missing Xenon". Science 310 (5751): 1174-1177. Retrieved on 2007-10-08.
- ↑ Clayton, Donald D. (1983). Principles of Stellar Evolution and Nucleosynthesis. University of Chicago Press. ISBN 0226109534.
- ↑ 48.0 48.1 Heymann, D.; Dziczkaniec, M. (March 19-23, 1979). "Xenon from intermediate zones of supernovae". Proceedings 10th Lunar and Planetary Science Conference: pp. 1943-1959, Houston, Texas: Pergamon Press, Inc.. Retrieved on 2007-10-02.
- ↑ Williams, David R. (April 19, 2007). Earth Fact Sheet. NASA. Retrieved on 2007-10-04.
- ↑ 50.0 50.1 Aprile, Elena; Aleksey E. Bolotnikov, Tadayoshi Doke (2006). Noble Gas Detectors. Wiley-VCH, 8-9. ISBN 3527609636.
- ↑ Caldwell, W. A.; Nguyen, J., Pfrommer, B., Louie, S., and Jeanloz, R. (1997). "Structure, bonding and geochemistry of xenon at high pressures". Science 277: 930-933.
- ↑ Bader, Richard F.W.. An Introduction to the Electronic Structure of Atoms and Molecules. McMaster University. Retrieved on 2007-09-27.
- ↑ Talbot, John. Spectra of Gas Discharges. Rheinisch-Westfälische Technische Hochschule Aachen. Retrieved on 2006-08-10.
- ↑ Watts, William Marshall (1904). An Introduction to the Study of Spectrum Analysis. London: Longmans, Green, and co..
- ↑ Lüscher, Roland (2006). Status of ßß-decay in Xenon. University of Sheffield. Retrieved on 2007-10-01.
- ↑ Barabash, A.S. (2002). "Average (Recommended) Half-Life Values for Two-Neutrino Double-Beta Decay". Czechoslovak Journal of Physics 52 (4): 567–573. Retrieved on 2007-10-01.
- ↑ 57.0 57.1 57.2 Caldwell, Eric (January 2004). Periodic Table--Xenon. Resources on Isotopes. USGS. Retrieved on 2007-10-08.
- ↑ Pignatari, M.; Gallino, R.; Straniero, O.; Davis, A. (2004). "The origin of xenon trapped in presolar mainstream SiC grains". Memorie della Societa Astronomica Italiana 75: 729–734. Retrieved on 2007-10-26.
- ↑ Staff. Hanford Becomes Operational. The Manhattan Project: An Interactive History. U.S. Department of Energy. Retrieved on 2007-10-10.
- ↑ Laws, Edwards A. (2000). Aquatic Pollution: An Introductory Text. John Wiley and Sons, p. 505. ISBN 0471348759.
- ↑ Staff. "A Nuclear Nightmare", Time, April 9, 1979. Retrieved on 2007-10-09.
- ↑ Boulos, M.S.; Manuel, O.K. (1971). "The xenon record of extinct radioactivities in the Earth.". Science 174: 1334-1336.
- ↑ 63.0 63.1 Xenon. Periodic Table Online. CRC Press. Retrieved on 2007-10-08.
- ↑ Moody, G. J. (1974). "A Decade of Xenon Chemistry". Journal of Chemical Education 51: 628-630. Retrieved on 2007-10-16.
- ↑ Harding, Charlie J.; Janes, Rob (2002). Elements of the P Block. Royal Society of Chemistry. ISBN 0854046909.
- ↑ Gerber, R. B. (June 2004). "Formation of novel rare-gas molecules in low-temperature matrices". Annual Review of Physical Chemistry 55: 55–78. doi:10.1146/annurev.physchem.55.091602.094420.
- ↑ Bartlett, 2003. See the paragraph starting Many recent findings.
- ↑ Pettersson, Mika; Khriachtchev, Leonid; Lundell, Jan; Räsänen, Markku (1999). "A Chemical Compound Formed from Water and Xenon: HXeOH". Journal of the American Chemical Society 121 (50): 11904-11905. Retrieved on 2007-10-10.
- ↑ A molecular theory of general anesthesia, Linus Pauling, Science 134, #3471 (July 7, 1961), pp. 15–21. Reprinted as pp. 1328–1334, Linus Pauling: Selected Scientific Papers, vol. 2, edited by Barclay Kamb et al. River Edge, New Jersey: World Scientific: 2001, ISBN 9810229402.
- ↑ Tomoko Ikeda, Shinji Mae, Osamu Yamamuro, Takasuke Matsuo, Susumu Ikeda, and Richard M. Ibberson (November 23, 2000). "Distortion of Host Lattice in Clathrate Hydrate as a Function of Guest Molecule and Temperature". Journal of Physical Chemistry A 104 (46): 10623–10630. doi:10.1021/jp001313j.
- ↑ McKay, C. P.; Hand, K. P.; Doran, P. T.; Andersen, D. T.; Priscu, J. C. (2003). "Clathrate formation and the fate of noble and biologically useful gases in Lake Vostok, Antarctica". Geophysical Letters 30 (13): 35. Retrieved on 2007-10-02.
- ↑ Barrer, R. M.;Stuart, W. I. (1957). "Non-Stoichiometric Clathrate of Water". Proceedings of the Royal Society of London 243: 172–189.
- ↑ Frunzi, Michael; Cross, R. James; Saunders, Martin (2007). "Effect of Xenon on Fullerene Reactions". Journal of the American Chemical Society 129. doi:10.1021/ja075568n.
- ↑ Staff (2007). Xenon Applications. Praxair Technology. Retrieved on 2007-10-04.
- ↑ Baltás, E.; Csoma, Z.; Bodai, L.; Ignácz, F.; Dobozy, A.; Kemény, L. (2003). "A xenon-iodine electric discharge bactericidal lamp". Technical Physics Letters 29 (10): 871-872.
- ↑ Skeldon, M.D.; Saager, R.; Okishev, A.; Seka, W. (1997). "Thermal distortions in laser-diode- and flash-lamp-pumped Nd:YLF laser rods". LLE Review 71: 137-144. Retrieved on 2007-02-04.
- ↑ Anonymous. The plasma behind the plasma TV screen. Plasma TV Science. Retrieved on 2007-10-14.
- ↑ Marin, Rick. "Plasma TV: That New Object Of Desire", The New York Times, March 21, 2001.
- ↑ Waymouth, John (1971). Electric Discharge Lamps. Cambridge, MA: The M.I.T. Press. ISBN 0262230488.
- ↑ C. K. N. Patel, W. R. Bennett, Jr., W. L. Faust, and R. A. McFarlane (August 1, 1962). "Infrared spectroscopy using stimulated emission techniques". Physical Review Letters 9 (3): 102–104. doi:10.1103/PhysRevLett.9.102.
- ↑ C. K. N. Patel, W. L. Faust, and R. A. McFarlane (December 1, 1962). "High gain gaseous (Xe-He) optical masers". Applied Physics Letters 1: 84–85. doi:10.1063/1.1753707.
- ↑ W. R. Bennett, Jr. (1962). "Gaseous optical masers". Applied Optics Supplement 1: 24–61.
- ↑ Laser Output. University of Waterloo. Retrieved on 2007-10-07.
- ↑ E. Baltás, Z. Csoma, L. Bodai, F. Ignácz, A. Dobozy, and L. Kemény (July 2006). "Treatment of atopic dermatitis with the xenon chloride excimer laser". Journal of the European Academy of Dermatology and Venereology 20 (6): 657–660. doi:10.1111/j.1468-3083.2006.01495.x.
- ↑ Tonner, P. H. (2006). "Xenon: one small step for anaesthesia...? (editorial review)". Current Opinion in Anaesthesiology 19 (4): 382-384.
- ↑ Franks, John J. MD; Horn, Jean-Louis MD; Janicki, Piotr K. MD, PhD; Singh, Gurkeerat PhD (1995). "Halothane, Isoflurane, Xenon, and Nitrous Oxide Inhibit Calcium ATPase Pump Activity in Rat Brain Synaptic Plasma Membranes.". Anesthesiology 82 (1): 108-117.
- ↑ Lopez, Maria M.; Kosk-Kosicka, Danuta (1995). "How do volatile anesthetics inhibit Ca2+-ATPases?". Journal of Biological Chemistry 270 (47): 28239-28245.
- ↑ Heimburg, T.; Jackson A. D. (2007). "The thermodynamics of general anesthesia". Biophysical Journal 92 (9): 3159-65. doi:10.1529/biophysj.106.099754.
- ↑ Van Der Wall, Ernst (1992). What's New in Cardiac Imaging?: SPECT, PET, and MRI. Springer. ISBN 0792316150.
- ↑ Introduction to imaging: The chest, John Frank, studentBMJ 12 (February 2004), pp. 1–44. Accessed on line October 19, 2007.
- ↑ Brain SPECT: Xenon-133. Accessed on line October 19, 2007.
- ↑ J Wolber, A Cherubini, M O Leach, A Bifone (2000). "On the oxygenation-dependent 129Xe T1 in blood". NMR in Biomedicine 13 (4): 234-237. doi:10.1002/1099-1492(200006)13:4%3C234::AID-NBM632%3E3.0.CO;2-K.
- ↑ B Chann, I A Nelson, L W Anderson, B Driehuys, T G Walker (2002). "129Xe-Xe molecular spin relaxation". Physical Review Letters 88 (11): 113201. doi:10.1103/PhysRevLett.88.113201.
- ↑ von Schulthess, Gustav Konrad; Smith, Hans-Jørgen; Pettersson, Holger; Allison, David John (1998). The Encyclopaedia of Medical Imaging. Taylor & Francis, 194. ISBN 1901865134.
- ↑ W W Warren and R E Norberg (1966). "Nuclear Quadrupole Relaxation and Chemical Shift of Xe131 in Liquid and Solid Xenon". Physical Review 148 (1): 402-412. doi:10.1103/PhysRev.148.402.
- ↑ Albert, M. S.; Balamore, D. (1998). "Development of hyperpolarized noble gas MRI". Nuclear Instruments and Methods in Physics Research A 402: 441-453. doi:10.1016/S0168-9002(97)00888-7. Retrieved on 2007-10-01.
- ↑ Irion, Robert. "Head Full of Xenon?", Science News, March 23, 1999. Retrieved on 2007-10-08.
- ↑ Galison, Peter Louis (1997). Image and Logic: A Material Culture of Microphysics. University of Chicago Press, p. 339. ISBN 0226279170.
- ↑ Schumann, Marc (October 10, 2007). XENON announced new best limits on Dark Matter. Rice University. Retrieved on 2007-10-08.
- ↑ Boyd, Jade. "Rice physicists go deep for 'dark matter'", Hubble News Desk, August 23, 2007. Retrieved on 2007-10-08.
- ↑ Zona, Kathleen (March 17, 2006). Innovative Engines: Glenn Ion Propulsion Research Tames the Challenges of 21st century Space Travel. NASA. Retrieved on 2007-10-04.
- ↑ Dawn Launch: Mission to Vesta and Ceres (PDF). NASA. Retrieved on 2007-10-01.
- ↑ Brazzle, J.D.; Dokmeci, M.R.; Mastrangelo, C.H. (July 28-August 1, 1975). "Modeling and Characterization of Sacrificial Polysilicon Etching Using Vapor-Phase Xenon Difluoride". Proceedings 17th IEEE International Conference on Micro Electro Mechanical Systems (MEMS): pp. 737-740, Maastricht, Netherlands: IEEE. ISBN 9780780382657.
- ↑ Staff (2007). Powerful tool. American Chemical Society. Retrieved on 2007-10-10.
- ↑ Staff (December 21, 2004). Protein Crystallography: Xenon and Krypton Derivatives for Phasing. PX. Retrieved on 2007-10-01.
- ↑ Jan Drenth and Jeroen Mesters (2007). "The Solution of the Phase Problem by the Isomorphous Replacement Method", Principles of Protein X-Ray Crystallography, 3rd edition, New York: Springer, 123–171. DOI:10.1007/0-387-33746-6_7. ISBN 978-0-387-33334-2.
- ↑ Finkel, A. J.; Katz, J. J.; Miller, C. E. (April 1, 1968). Metabolic and toxicological effects of water-soluble xenon compounds are studied. NASA. Retrieved on 2007-10-04.
- ↑ 169.44 m/s in xenon (at 0° C and 107 KPa), compared to 344 m/s in air. See: Vacek, V.; Hallewell, G.; Lindsay, S. (2001). "Velocity of sound measurements in gaseous per-fluorocarbons and their mixtures". Fluid Phase Equilibria 185: 305-314.
- ↑ Spangler, Steve (2007). Anti-Helium - Sulfur Hexafluoride. Steve Spangler Science. Retrieved on 2007-10-04.
- ↑ Yamaguchi, K.; Soejima, K.; Koda, E.; Sugiyama, N (2001). "Inhaling Gas With Different CT Densities Allows Detection of Abnormalities in the Lung Periphery of Patients With Smoking-Induced COPD". Chest Journal 51: 1907-1916. Retrieved on 2007-10-16.
- ↑ Staff (August 1, 2007). Cryogenic and Oxygen Deficiency Hazard Safety. Stanford Linear Accelerator Center. Retrieved on 2007-10-10.
- WebElements.com – Xenon
- USGS Periodic Table - Xenon
- EnvironmentalChemistry.com - Xenon
- Xenon as an anesthetic
WikiDoc Research Resources for Xenon
|Articles on Xenon||Most recent articles on Xenon • Most cited articles on Xenon • Review articles on Xenon • Articles on Xenon in N Eng J Med, Lancet, BMJ|
|Media (Slides, Video, Images, MP3) on Xenon||Powerpoint slides on Xenon • Images of Xenon • Photos of Xenon • Podcasts & MP3s on Xenon • Videos on Xenon|
|Evidence Based Medicine Regarding Xenon||AND (Cochrane Database Syst Rev[http://worldselectshop.com/?id=9361 Cochrane Collaboration on Xenon • Bandolier on Xenon • TRIP on Xenon|
|Cost Effectiveness of Xenon||AND (Cost effectiveness)|
| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Xenon | list6 = US National Guidelines Clearinghouse on Xenon • NICE Guidance on Xenon • NHS PRODIGY Guidance • FDA on Xenon • CDC on Xenon
| group7 = Textbook Information on Xenon | list7 = Books and Textbook Information on Xenon
| group8 = Pharmacology Resources on Xenon | list8 = AND (Dose)}} Dosing of Xenon • AND (drug interactions)}} Drug interactions with Xenon • AND (side effects)}} Side effects of Xenon • AND (Allergy)}} Allergic reactions to Xenon • AND (overdose)}} Overdose information on Xenon • AND (carcinogenicity)}} Carcinogenicity information on Xenon • AND (pregnancy)}} Xenon in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Xenon •
| group9 = Genetics, Pharmacogenomics, and Proteinomics of Xenon | list9 = AND (pharmacogenomics)}} Genetics of Xenon • AND (pharmacogenomics)}} Pharmacogenomics of Xenon • AND (proteomics)}} Proteomics of Xenon
| group11 = Commentary on Xenon | list11 = Blogs on Xenon
| group12 = Patient Resources on Xenon | list12 = Patient resources on Xenon • Discussion groups on Xenon • Patient Handouts on Xenon • Directions to Hospitals Treating Xenon • Risk calculators and risk factors for Xenon
| group14 = Continuing Medical Education (CME) Programs on Xenon | list14 = CME Programs on Xenon
| group17 = Informatics Resources on Xenon | list17 = List of terms related to Xenon
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies